Uploaded on May 1, 2024
According to the latest research report by IMARC Group, The global veterinary molecular diagnostics market size reached US$ 690.8 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,391.9 Million by 2032, exhibiting a growth rate (CAGR) of 7.9% during 2024-2032. More Info:- https://www.imarcgroup.com/veterinary-molecular-diagnostics-market
Veterinary Molecular Diagnostics Market Growth, Demand and Challenges of the Key Industry Players 2024-2032
Global Veterinary
Molecular Diagnostics
Market Research and
Forecast Report 2024-
2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved
About IMARC Group
In ternat ional Market Analys is Research and Consul t ing Group is a leading adv iser on management
s t rategy and market research wor ldwide. We par tner wi th c l ients in a l l regions and indust ry
vert ica ls to ident i fy thei r h ighest -value oppor tuni t ies, address thei r most cr i t ica l chal lenges, and
t ransform thei r bus inesses.
IMARC’s in format ion products inc lude major market , sc ient i f ic , economic and technological
developments for bus iness leaders in pharmaceut ica l , indust r ia l , and h igh technology
organizat ions. Market forecasts and indust ry analys is for b iotechnology, advanced mater ia ls ,
chemicals , food and beverage, t ravel and tour ism, nanotechnology and novel process ing methods
are at the top of the company’s exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight in to the dynamics o f companies and
markets wi th c lose cooperat ion at a l l levels of the c l ient organizat ion. This ensures that our c l ients
achieve unmatchable compet i t ive advantage, bui ld more pro f ic ient organizat ions, and secure
las t ing resul ts .
A cc o r d i ng t o t h e l a t e s t r e p o r t b y IM A R C Gr o u p , t i t l e d " V e t e r i n a r y M o l e c u l a r
D ia g n o s t i c s M a r k e t : G l o b a l I n d u s t r y T r e n d s , S h a r e , S i z e , G ro w t h , Op p o r t u n i t y a n d
F o r e c a s t 2 0 2 4 - 2 0 3 2 , " t h e g l ob a l v e t e r i n a r y m o l e cu l a r d i a g n o s t i c s m a rk e t s i z e re a c h ed
U S $ 6 9 0 . 8 M i l l i o n i n 2 02 3 .
Report V e t e r i n a ry m o l e c u l a r d i a g n o s t i c s c o m p r i s e a d v a nc e d l a b o r a t o r y m e t h o d s t o de t e c t , i d e n t i f y , a nd g en o t y pe v a r i o u s v i r a l , b a c t e r i a l , a n d v e c t o r -b o r n e p a t h o g e ns a m o ng
an i ma l s . S o m e c om m o n l y u t i l i z e d mo l e c u l a r - b a se d t e c h n i qu e s i n c l ud e p o l y me r as e
Highlight and ch a i n r e ac t i o n ( P C R ) , i n s i t u h y b r i d i za t i o n ( I S H ) , n uc l e i c ac i d s eq u e n c e - b a s e d am p l i f i c a t i o n ( N A S B A ) , a n d p r o t e o m i c s .
T he y a i d c l i n i c i a ns i n e x a m i n i n g t h e r i b on u c l e i c a c i d ( R N A ) , d e o x y r i b o n u c l e i c ac i d
Description ( D N A ) , o r o t h e r p r o t e i n s i n a n i m a l s t o d i ag n o s e d i s e a s es o r t h e p r e d i s po s i t i o n s t a g e .
I n r e c e n t y e a r s , ve t e r i na r y m o l e c u l a r d i a g n o s t i c s h a v e g a i n e d i m me n s e t r a c t i o n a c r o ss
r es e a r ch l a b o r a t o r i e s a nd v e t e r i n a r y he a l t h c e n t e rs s i n c e th e y f a c i l i t a t e r a p i d a nd
h i g h l y a cc u r a t e d e t e c t i o n o f n u c l e i c a c i d s a n d d i ag n o s i s o f i n f ec t i o us d i s e a se s .
R eq u e s t f o r a P D F sa m p le o f th i s r ep o r t :
h t t p s : / /w w w . i ma r c g r o u p . co m / ve t e r i n a r y - m o l e c u l a r -d i a g n o s t i c s - ma r k e t / r e q u es t s a mp l e
Report Description
G lo b a l V e t e r in a r y M o le c u la r D i a g n o s t i c s M a r k e t T r e n d s :
T h e s u r g i n g i n c i d e n c e s o f z o o n o t i c d i s e a s e s a n d t h e r i s i n g a n i m a l h u s b a n d r y a c t i v i t i e s r e p r e s e n t t h e p r i m a r y f a c t o r s d r i v i n g t h e
m a r k e t g r o w t h . B e s i d e s t h i s , t h e e x p a n d i n g l i v e s t o c k p o p u l a t i o n d u e t o t h e e s c a l a t i n g d e ma n d f o r a n i m a l - d e r i v e d p r o d u c t s i s
a n o th e r m a j o r g r o w t h - i n d u c i n g f a c t o r . I n a d d i t i o n , t h e r e h a s b e e n w i d e s p r e a d a d o p t i o n o f v e te r i n a r y m o l e c u l a r d i a g n o s t i c s d u e t o
g r o w i n g f o o d s a fe t y c o n c e r n s . A l o n g w i t h t h i s , t h e i n c r e a s i n g p e t o w n e r s h i p r a te s a n d t h e e m e r g i n g p e t h u m a n i z a t i o n t r e n d h a v e
a u g m e n te d t h e p r o d u c t d e m a n d o w i n g t o t h e r i s i n g a w a r e n e s s a b o u t a n i m a l h e a l t h a n d w e l l b e i n g a m o n g p e t p a r e n t s . F u r t h e r m o r e ,
t h e r e c e n t a d v a n c e m e n t s i n p r o t e o m i c s a n d n a n o te c h n o l o g y h a v e l e d t o t h e d e v e l o p m e n t o f i n n o v a t i v e , f u l l y a u t o m a t e d , a n d h i g h
t h r o u g h p u t s y s t e m s . I n l i n e w i t h t h i s , t h e s u r g i n g d e m a n d f o r c u s t o m i z e d r e a g e n t s a n d k i t s h a s c a ta l y z e d m a r k e t g r o w t h .
M o r e o v e r , t h e s u d d e n o u t b r e a k o f c o r o n a v i r u s d i s e a s e ( C O V I D - 1 9 ) h a s a c c e l e r a t e d t h e a d o p t i o n o f P C R te s t i n g t o e x a m i n e t h e
e f f e c t o f t h e i n f e c t i o n i n a n i m a l s . O th e r f a c to r s , i n c l u d i n g t h e l a u n c h o f a d v a n c e d g e n o t y p i n g t e c h n i q u e s , f a v o r a b l e g o v e r n m e n t
i n i t i a t i v e s , r i s i n g a d o p t i o n o f p e t i n s u r a n c e p o l i c i e s , i n c r e a s i n g p e t h e a l t h c a r e e x p e n d i t u r e , d e v e l o p m e n t i n t h e a n i m a l h e a l t h c a r e
s e c to r , a n d p r o d u c t i n n o v a t i o n s , a r e a l s o p r o v i d i n g a p o s i t i v e t h r u s t t o t h e m a r k e t g r o w t h .
L o o k in g f o r w a r d , I M A R C G r o u p e x p e c t s t h e m a r k e t v a lu e t o r e a c h U S $ 1 , 3 9 1 .9 M i l l i o n b y 2 0 3 2 , e x p a n d i n g a t a C A G R o f
7 . 9 % d u r in g t h e f o r e c a s t p e r i o d ( 2 0 2 4 - 2 0 3 2 ) .
V ie w R e p o r t T O C , F i g u r e s a n d T a b l e s : h t t p s : / / w w w . i m a r c g r o u p . c o m / v e t e r i n a r y - m o le c u l a r - d i a g n o s t ic s - m a r k e t
Breakup by Product:
• Kits and Reagents
• Instruments
• Software and Services
Breakup by Technology:
• Real Time PCR
Report • Microarray
• DNA Sequencing
Segmentation
Breakup by Animal Type:
• Companion Animal
• Livestock An imal
Breakup by Disease Type:
• Vector-borne Diseases
• Resp iratory Pathogens
• Diarrhea Pathogens
• Others
Breakup by End User:
• Veter inary Hospita ls
• Cl in ical Laborator ies
• Research Inst i tutes
Report
Segmentation Breakup by Region:
• North America
• Asia-Pacifi c
• Europe
• Lat in America
• Middle East and Afr ica
• Biochek B.V.
• bioMérieux SA
• HealthGene Corporation
•
Competitive Heska Corporation
• IDEXX Laboratories Inc.
Landscape • INDICAL BIOSCIENCE GmbH
with Key • Ingenetix GmbH
Players • NEOGEN Corporation
• Qiagen N.V
• Thermo Fisher Scient ifi c Inc.
• Veterinary Molecular Diagnostics Inc.
• Zoetis Inc.
What was the size of the global veterinary
molecular diagnostics market in 2023?
What is the expected growth rate of the global
veterinary molecular diagnostics market during
2024-2032?
Key
Questions What are the key factors driving the global veterinary molecular diagnostics market?
Answered in
What has been the impact of COVID-19 on the
the Report global veterinary molecular diagnostics market?
What is the breakup of the global veterinary
molecular diagnostics market based on the
product?
What is the breakup of the global veterinary
molecular diagnostics market based on the
technology?
What is the breakup of the global veterinary
molecular diagnostics market based on the animal
type?
What is the breakup of the global veterinary
molecular diagnostics market based on the disease
type?
Key
What are the key regions in the global veterinary
Questions molecular diagnostics market?
Answered in Who are the key players/companies in the global
veterinary molecular diagnostics market?
the Report
1 P r e f a c e
2 S c o p e a n d M e t h o d o l o g y
2 . 1 O b j e c t i v e s o f t h e S t u d y
2 . 2 S t a k e h o l d e r s
2 . 3 D a t a S o u r c e s
2 . 3 . 1 P r i m a r y S o u r c e s
2 . 3 . 2 S e c o n d a r y S o u r c e s
2 . 4 M a r k e t E s t i m a t i o n
2 . 4 . 1 B o t t o m - U p A p p r o a c h
Table of 2 . 4 . 2 T o p - D o w n A p p r o a c h 2 . 5 F o r e c a s t i n g M e t h o d o l o g y
3 E x e c u t i v e S u m m a r y
4 I n t r o d u c t i o n
4 . 1 O v e r v i e w
Contents 4 . 2 K e y I n d u s t r y T r e n d s5 G l o b a l V e t e r i n a r y M o l e c u l a r D i a g n o s t i c s M a r k e t
5 . 1 M a r k e t O v e r v i e w
5 . 2 M a r k e t P e r f o r m a n c e
5 . 3 I m p a c t o f C O V I D - 1 9
5 . 4 M a r k e t F o r e c a s t
6 M a r k e t B r e a k u p b y P r o d u c t
6 . 1 K i t s a n d R e a g e n t s
6 . 1 . 1 M a r k e t T r e n d s
6 . 1 . 2 M a r k e t F o r e c a s t
6 . 2 I n s t r u m e n t s
6 . 2 . 1 M a r k e t T r e n d s
6 . 2 . 2 M a r k e t F o r e c a s t
6 . 3 S o f t w a r e a n d S e r v i c e s
6 . 3 . 1 M a r k e t T r e n d s
6 . 3 . 2 M a r k e t F o r e c a s t
7 M a r k e t B r e a k u p b y T e c h n o l o g y
7 . 1 R e a l T i m e P C R
7 . 1 . 1 M a r k e t T r e n d s
7 . 1 . 2 M a r k e t F o r e c a s t
7 . 2 M i c r o a r r a y
7 . 2 . 1 M a r k e t T r e n d s
7 . 2 . 2 M a r k e t F o r e c a s t
7 . 3 D N A S e q u e n c i n g
7 . 3 . 1 M a r k e t T r e n d s
7 . 3 . 2 M a r k e t F o r e c a s t
8 M a r k e t B r e a k u p b y A n i m a l T y p e
8 . 1 C o m p a n i o n A n i m a l
Table of 8 . 1 . 1 M a r k e t T r e n d s 8 . 1 . 2 M a r k e t F o r e c a s t
8 . 2 L i v e s t o c k A n i m a l
Contents 8 . 2 . 1 M a r k e t T r e n d s 8 . 2 . 2 M a r k e t F o r e c a s t
9 M a r k e t B r e a k u p b y D i s e a s e T y p e
9 . 1 V e c t o r - b o r n e D i s e a s e s
9 . 1 . 1 M a r k e t T r e n d s
9 . 1 . 2 M a r k e t F o r e c a s t
9 . 2 R e s p i r a t o r y P a t h o g e n s
9 . 2 . 1 M a r k e t T r e n d s
9 . 2 . 2 M a r k e t F o r e c a s t
9 . 3 D i a r r h e a P a t h o g e n s
9 . 3 . 1 M a r k e t T r e n d s
9 . 3 . 2 M a r k e t F o r e c a s t
9 . 4 O t h e r s
9 . 4 . 1 M a r k e t T r e n d s
9 . 4 . 2 M a r k e t F o r e c a s t
F o r m o r e i n f o r m a t i o n , v i s i t :
ht t ps : / /w ww. i ma rc gro up . c o m /v e t e r i na ry -m o l ec u la r-d i a gno s t i c
s -m a rke t / t o c
Disclaimer
© 2023 IMARC Al l R ights Reserved
Th is Pub l i ca t ion and a l l i t ’ s con ten ts un less o therw ise men t i oned a re copy r i gh ted in the name o f
I n t e rna t i ona l Marke t Ana lys i s Research and Consu l t ing ( IMARC) . No pa r t o f t h i s pub l i ca t ion may be
rep roduced , repackaged , red i s t r i bu ted o r res o ld i n who le o r i n any pa r t . The pub l i ca t ion may a l so
no t be used i n any f o rm o r by and means g raph i c e lec t ron ic o r mechan ic a l , i nc lud ing pho tocopy ing ,
reco rd ing , t ap ing o r by i n fo rmat i on s to rage o r re t r ieva l , o r by any o the r f o rm, w i t hou t the exp ress
c ons en t o f I n t e rna t iona l Marke t Ana lys i s Research and Consu l t i ng ( IMARC) .
Disc la imer : Al l con ten ts and da ta o f t h i s pub l i c a t i on , i nc lud ing fo recas t s , da ta ana lys i s and op in ion
have been based on in f o rmat ion and sources be l ieved to be accu ra te and re l iab le a t t he t ime o f
pub l i sh ing . In t e rna t i ona l Ma rke t Ana l ys is Research and Consu l t ing makes no rep resen ta t ion o f
war ran t y o f any k ind as to t he acc u racy o r comp le teness o f any I n fo rmat i on p rov ided . IMARC
accep ts no l i ab i l i t y wha tsoever f o r any los s o r damage resu l t i ng f rom op in ion , e r ro rs o r
i naccu rac ies i f any f ound th is pub l i ca t ion .
IMARC, IMARC Group and G loba l Therapy I ns igh t Ser i es a re reg is t e red t rademarks o f I n te rna t iona l
Marke t Ana lys i s Research and Consu l t ing . A l l o the r t rademarks used i n th i s pub l i ca t i on a re
reg i s te red t rademarks o f t he i r r espec t i ve compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
TELEPHONE: +1-631-791-1145
E-MAIL: [email protected]
Comments